Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.47 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.41 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.41 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | FAAH | O00519 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | CNR1 | P21554 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9819300 | 0.89 | PPARD (0.38) | CYP3A4LPAR3LPAR1LPAR2MEN1 | |
| SCHEMBL4267682 | 0.83 | CYP3A4 (0.48) | CYP3A4MEN1KMT2ATSHR | |
| SCHEMBL5839773 | 0.80 | PPARD (0.56) | CYP3A4MEN1FAAHTP53CYP1A2 | |
| SCHEMBL11494792 | 0.80 | CYP3A4 (0.45) | CYP3A4LPAR3LPAR1LPAR2TSHR | |
| SCHEMBL2239484 | 0.80 | DGKA (0.48) | CYP3A4LPAR3LPAR1 | |
| SCHEMBL10832782 | 0.80 | CYP3A4 (0.64) | CYP3A4LPAR3LPAR1LPAR2TSHR | |
| SCHEMBL2350307 | 0.79 | CYP3A4 (0.44) | CYP3A4LPAR3LPAR1LPAR2CYP1A2 | |
| SCHEMBL15951687 | 0.79 | DGKA (0.47) | CYP3A4LPAR3LPAR1LPAR2 | |
| SCHEMBL27975578 | 0.78 | AKR1B1 (0.48) | CYP3A4MEN1KMT2ATSHR | |
| SCHEMBL11514808 | 0.78 | CYP3A4 (0.61) | CYP3A4LPAR3LPAR1LPAR2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7396588-B2 | Curable composition, varnish and laminate | ZEON CORPORATION (JP) | 2008-07-08 | — | — | US | disclosed |
| US-7317046-B2 | Cyclic phosphazenes, process for preparing them, flame retardant containing them as active ingredient, and resin composition containing them and molded article therefrom | CHEMIPRO KASEI KAISHA, LIMITED (JP) | 2008-01-08 | — | — | US | disclosed |
| US-20070060674-A1 | Curable composition, varnish and laminate | ZEON CORPRATION (JP) | 2007-03-15 | — | — | US | disclosed |
| US-7160609-B2 | Curable composition, varnish, and layered product | ZEON CORPORATION (JP) | 2007-01-09 | — | — | US | disclosed |
| US-20050159509-A1 | Varnish, shaped item, electrical insulating film, laminate, flame retardant slurry and process for producing flame retardant particles and varnish | ZEON CORPORATION (JP) | 2005-07-21 | — | — | US | disclosed |
| US-20040152910-A1 | Cyclic phosphazenes, process for preparing them, flame retardants containing the same as the active ingredient, and resin composition containing and molded articles containing the flame retardants | CHEMIPRO KASEI KAISHA, LIMITED (JP) | 2004-08-05 | — | — | US | disclosed |
| EP-1403273-A1 | CYCLIC PHOSPHAZENES, PROCESS FOR PREPARING THEM, FLAME RETARDANTS CONTAINING THE SAME AS THE ACTIVE INGREDIENT, AND RESIN COMPOSITIONS AND MOLDED ARTICLES CONTAINING THE FLAME RETARDANTS | Chemipro Kasei Kaisha, Limited (JP) | 2004-03-31 | — | — | EP | disclosed |
| US-20040025743-A1 | Curable composition, varnish, and layered product | ZEON CORPORATION (JP) | 2004-02-12 | — | — | US | disclosed |
| US-6139998-A | OPTICAL ELEMENTS WITH POLYMER RESIN ON SUBSTRATES INNER SURFACE OF THE CYLINDRICAL SUBSTRATE IS NOT MORE THAN 0.5 .MU.M. THE ELECTROPHOTOGRAPHIC PHOTORECEPTOR EMPLOYING THE SUBSTRATE IS | KONICA CORPORATION (JP) | 2000-10-31 | — | — | US | disclosed |
| US-4585703-A | MELAMINE RESIN AND PHOSPHONATE FIREPROOFING AGENT | DAINIPPON INK & CHEMICALS, INC. (JP) | 1986-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040152910-A1 | Cyclic phosphazenes, process for preparing them, flame retardants containing the same as the active ingredient, and resin composition containing and molded articles containing the flame retardants | PFAS, AFF1, PHOSPHO1 | CYP3A4 2438/4885LPAR3 1741/4885LPAR1 1177/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.